This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
10 - 12 June, 2025
Congress CenterBasel Switzerland

Namrata Jayanth, PhD
Research Leader at Charles River Laboratories
Speaker

Profile

Namrata Jayanth, PhD, is a Research Leader in the Biotherapeutics Drug Discovery Division at Charles River Laboratories, The Netherlands, with over 15 years of experience in cancer cell biology, in vitro pharmacology, and drug discovery. She specializes in integrated drug discovery and preclinical development of therapeutic antibodies and small molecules for oncology and immunology portfolios. Before joining Charles River Laboratories, Namrata served as Discovery Biology Team Lead at Bristol Myers Squibb Research Centre. Her academic career includes postdoctoral research at Massachusetts Institute of Technology (MIT), USA, focusing on regulatory proteins and gene editing, as well a joint post-doctoral fellowship on cancer signaling pathways at University of Cambridge, UK and InStem, India. Namrata earned her PhD in Biochemistry and Biophysics from Tata Institute of Fundamental Research (TIFR), India.

Agenda Sessions

  • Advancing Antibody Therapeutics: Integrated Safety Profiling and Emerging Modalities

    11:20